Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Coherus BioSciences Inc (NASDAQ:CHRS)

13.50
Delayed Data
As of Sep 25
 +0.65 / +5.06%
Today’s Change
10.80
Today|||52-Week Range
31.48
-52.04%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$659.8M

Company Description

Coherus BioSciences, Inc. is a late-stage clinical biologics platform company, which engages in the development and commercializition of biosimilar therapeutics worldwide. It focuses on global biosimilar market. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan Herman, Doug Farrar, and Steve Glover in September 2010 and is headquartered in Redwood City, CA.

Contact Information

Coherus BioSciences, Inc.
333 Twin Dolphin Drive
Redwood City California 94065
P:(800) 794-5434
Investor Relations:

Employees

Shareholders

Mutual fund holders44.98%
Other institutional43.05%
Individual stakeholders42.78%

Top Executives

Denny M. LanfearChairman, President & Chief Executive Officer
Jean-Frédéric ViretChief Financial Officer
Alan C. HermanChief Scientific Officer
Peter K. WatlerChief Technical Officer
Barbara K. FinckChief Medical Officer